Xuwen Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xuwen Xu has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Shaohang Cai
Department of Infectious Diseases, Nanfang Hospital, Southern Medical University
7 shared publications Jie Peng
Department of Infectious Diseases, Nanfang Hospital, Southern Medical University
5 shared publications- Jie Peng
Department of Infectious Diseases, Nanfang Hospital, Southern Medical University
5 shared publications Shaohang Cai
Department of Infectious Diseases, Nanfang Hospital, Southern Medical University
4 shared publicationsYuyuan Xu
Department of Infectious Diseases , Nanfang Hospital Guangzhou, Guangdong 510515 , China
4 shared publicationsGuangyu Liang
Department of Infectious Diseases, Nanfang Hospital Southern Medical University Guangzhou China
3 shared publications
Latest Publications
- Open Access
- 11 June 2026
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 11 (6) , 158
Reduced HAV IgG Seropositivity Among Unvaccinated People Living with HIV: The Weak Shield
People living with HIV (PLWH) represent a high-risk population for hepatitis A virus (HAV) infection, with exposure risk equal to or higher than that of the general population, particularly within adult risk networks. Anti-HAV immunoglobulin G (IgG) serves as a neutralizing antibody and is considered a key marker of protective immunity against HAV infection. However, the serologic profile of anti-HAV IgG and IgM among unvaccinated PLWH remains insufficiently characterized, especially in South China. A total of 1232 unvaccinated adults were enrolled in the study, including 800 PLWH and 432 HIV- negative controls, to evaluate the serological markers of HAV immunity. Serum anti-HAV IgG and immunoglobulin M (IgM) were measured using enzyme-linked immunosorbent assays, and demographic, immunological, and biochemical data were collected. We observed that PLWH had significantly lower anti-HAV IgG concentrations (0.27 ± 0.16 vs. 0.31 ± 0.14 ng/mL, p < 0.001) and a lower IgG seropositivity rate (22.5% vs. 35.6%, p < 0.001) compared with HIV-negative controls, whereas no differences were found in IgM levels or positivity between the two groups. Multivariable logistic regression identified HIV infection (OR = 0.599, 95% CI 0.413–0.869, p = 0.007) and age (OR = 1.019, 95% CI 1.007–1.031, p = 0.002) as independent factors associated with IgG seropositivity. Among PLWH, those who were IgG-positive tended to be older (p = 0.003) and had higher serum globulin levels (p < 0.001), whereas IgM positivity was linked to younger age (p < 0.001) and a higher CD4/CD8 ratio (p = 0.030). Age-stratified analyses further revealed that IgG seroprevalence increased with age, while IgM positivity showed a declining trend. These findings indicate a considerable immunity gap in a population at elevated risk of HAV infection and support the need for targeted serologic screening and vaccination strategies among PLWH.
- 11 June 2026
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 11 (6) , 158
Open AccessReduced HAV IgG Seropositivity Among Unvaccinated People Living with HIV: The Weak Shield
People living with HIV (PLWH) represent a high-risk population for hepatitis A virus (HAV) infection, with exposure risk equal to or higher than that of the general population, particularly within adult risk networks. Anti-HAV immunoglobulin G (IgG) serves as a neutralizing antibody and is considered a key marker of protective immunity against HAV infection. However, the serologic profile of anti-HAV IgG and IgM among unvaccinated PLWH remains insufficiently characterized, especially in South China. A total of 1232 unvaccinated adults were enrolled in the study, including 800 PLWH and 432 HIV- negative controls, to evaluate the serological markers of HAV immunity. Serum anti-HAV IgG and immunoglobulin M (IgM) were measured using enzyme-linked immunosorbent assays, and demographic, immunological, and biochemical data were collected. We observed that PLWH had significantly lower anti-HAV IgG concentrations (0.27 ± 0.16 vs. 0.31 ± 0.14 ng/mL, p < 0.001) and a lower IgG seropositivity rate (22.5% vs. 35.6%, p < 0.001) compared with HIV-negative controls, whereas no differences were found in IgM levels or positivity between the two groups. Multivariable logistic regression identified HIV infection (OR = 0.599, 95% CI 0.413–0.869, p = 0.007) and age (OR = 1.019, 95% CI 1.007–1.031, p = 0.002) as independent factors associated with IgG seropositivity. Among PLWH, those who were IgG-positive tended to be older (p = 0.003) and had higher serum globulin levels (p < 0.001), whereas IgM positivity was linked to younger age (p < 0.001) and a higher CD4/CD8 ratio (p = 0.030). Age-stratified analyses further revealed that IgG seroprevalence increased with age, while IgM positivity showed a declining trend. These findings indicate a considerable immunity gap in a population at elevated risk of HAV infection and support the need for targeted serologic screening and vaccination strategies among PLWH.
- Open Access
- 30 April 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1708360
Optimizing healthcare resources in pyogenic liver abscess: a dual-threshold HDL-CRP model for predicting hospitalization duration across multi-cohorts
Background: Prolonged hospitalization for pyogenic liver abscess (PLA) burdens patients and health systems. We examined whether admission high-density lipoprotein cholesterol (HDL-C) predicts length of stay (LOS) and whether a simple HDL–C-reactive protein (CRP) dual-threshold can flag patients at risk of prolonged stay. Methods: We analyzed a prospective adult PLA cohort at a tertiary center (2018–2023; n = 138) and validated findings in MIMIC-IV ICU patients with liver abscess ( n = 38) and in NHANES 2017–2020 ( n = 9,226). Multivariable models related admission HDL-C to log-transformed LOS; model performance and calibration were assessed with internal resampling and external validation. We further evaluated a dual-threshold rule and conducted mediation analysis with CRP. Results: Lower HDL-C independently associated with longer LOS. A nomogram combining HDL-C, abscess size, and sepsis performed well ( R 2 ≈0.66; RMSE≈6.4 d) and remained directionally consistent across external datasets. A dual-threshold (HDL-C < 1.03 mmol/L and CRP > 1.0 mg/dL) identified a high-risk subgroup with greater odds of prolonged stay. CRP mediated a small proportion of the HDL-C–LOS association. Conclusion: Admission HDL-C, particularly when interpreted together with CRP, may help identify PLA patients at increased risk of prolonged hospitalization at the time of admission. Patients with low HDL-C and high CRP may warrant closer monitoring, earlier evaluation for source control or drainage, and more proactive inpatient planning. Prospective implementation studies are warranted.
- 30 April 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1708360
Open AccessOptimizing healthcare resources in pyogenic liver abscess: a dual-threshold HDL-CRP model for predicting hospitalization duration across multi-cohorts
Background: Prolonged hospitalization for pyogenic liver abscess (PLA) burdens patients and health systems. We examined whether admission high-density lipoprotein cholesterol (HDL-C) predicts length of stay (LOS) and whether a simple HDL–C-reactive protein (CRP) dual-threshold can flag patients at risk of prolonged stay. Methods: We analyzed a prospective adult PLA cohort at a tertiary center (2018–2023; n = 138) and validated findings in MIMIC-IV ICU patients with liver abscess ( n = 38) and in NHANES 2017–2020 ( n = 9,226). Multivariable models related admission HDL-C to log-transformed LOS; model performance and calibration were assessed with internal resampling and external validation. We further evaluated a dual-threshold rule and conducted mediation analysis with CRP. Results: Lower HDL-C independently associated with longer LOS. A nomogram combining HDL-C, abscess size, and sepsis performed well ( R 2 ≈0.66; RMSE≈6.4 d) and remained directionally consistent across external datasets. A dual-threshold (HDL-C < 1.03 mmol/L and CRP > 1.0 mg/dL) identified a high-risk subgroup with greater odds of prolonged stay. CRP mediated a small proportion of the HDL-C–LOS association. Conclusion: Admission HDL-C, particularly when interpreted together with CRP, may help identify PLA patients at increased risk of prolonged hospitalization at the time of admission. Patients with low HDL-C and high CRP may warrant closer monitoring, earlier evaluation for source control or drainage, and more proactive inpatient planning. Prospective implementation studies are warranted.
- Open Access
- 14 January 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Longitudinal analysis of metabolic changes in people with HIV on integrase inhibitor-based versus efavirenz-based therapy: a prospective real-world cohort study in China
Background: Integrase strand transfer inhibitor (INSTI)-based antiretroviral therapy (ART) is recommended for HIV treatment but has been associated with metabolic adverse effects. However, real-world longitudinal data on these metabolic changes remain limited. This study aimed to characterize weight gain, dyslipidemia, and hepatic steatosis in ART-naïve people living with HIV (PLWH) initiating INSTI-based versus efavirenz (EFV)-based therapy. Methods: This prospective cohort study enrolled 772 participants at Nanfang Hospital, Southern Medical University from 2020 to 2023. Participants were categorized into 3 groups: EFV/tenofovir disoproxil fumarate (TDF)/lamivudine (3TC) ( n = 389); elvitegravir/cobicistat (EVG/c)/tenofovir alafenamide (TAF)/emtricitabine (FTC) or bictegravir (BIC)/TAF/FTC ( n = 168); and dolutegravir (DTG)/3TC or DTG/3TC/TDF ( n = 215). Metabolic parameters—including body mass index (BMI), lipids, and hepatic steatosis assessed via controlled attenuation parameter (CAP)—were evaluated at baseline, 6, 12, and 24 months using generalized estimating equations. Results: At 24 months, INSTI-based regimens were associated with significantly higher BMI compared to EFV/TDF/3TC (all P < 0.001), with no difference between INSTI subtypes. All groups showed early increases in triglycerides (TG) and total cholesterol (TC) that stabilized after 12 months; TG and TC levels at 24 months did not differ significantly between TAF-containing INSTI regimens and other groups. The prevalence of hepatic steatosis (CAP ≥ 238 dB/m) peaked at 31.2% at year 1 and declined to 28.8% at year 2. Multivariate analysis identified higher BMI (OR 1.55, 95% CI 1.44–1.67; p < 0.001), elevated TG (OR 1.44, 95% CI 1.22–1.70; p < 0.001), and elevated LDL-C (OR 1.90, 95% CI 1.21–2.98; p = 0.005) as independent risk factors. Conclusion: INSTI-based ART was associated with sustained weight gain but did not worsen long-term dyslipidemia compared to an EFV-based regimen in a real-world setting. Hepatic steatosis correlated with metabolic parameters rather than INSTI exposure.
- 14 January 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessLongitudinal analysis of metabolic changes in people with HIV on integrase inhibitor-based versus efavirenz-based therapy: a prospective real-world cohort study in China
Background: Integrase strand transfer inhibitor (INSTI)-based antiretroviral therapy (ART) is recommended for HIV treatment but has been associated with metabolic adverse effects. However, real-world longitudinal data on these metabolic changes remain limited. This study aimed to characterize weight gain, dyslipidemia, and hepatic steatosis in ART-naïve people living with HIV (PLWH) initiating INSTI-based versus efavirenz (EFV)-based therapy. Methods: This prospective cohort study enrolled 772 participants at Nanfang Hospital, Southern Medical University from 2020 to 2023. Participants were categorized into 3 groups: EFV/tenofovir disoproxil fumarate (TDF)/lamivudine (3TC) ( n = 389); elvitegravir/cobicistat (EVG/c)/tenofovir alafenamide (TAF)/emtricitabine (FTC) or bictegravir (BIC)/TAF/FTC ( n = 168); and dolutegravir (DTG)/3TC or DTG/3TC/TDF ( n = 215). Metabolic parameters—including body mass index (BMI), lipids, and hepatic steatosis assessed via controlled attenuation parameter (CAP)—were evaluated at baseline, 6, 12, and 24 months using generalized estimating equations. Results: At 24 months, INSTI-based regimens were associated with significantly higher BMI compared to EFV/TDF/3TC (all P < 0.001), with no difference between INSTI subtypes. All groups showed early increases in triglycerides (TG) and total cholesterol (TC) that stabilized after 12 months; TG and TC levels at 24 months did not differ significantly between TAF-containing INSTI regimens and other groups. The prevalence of hepatic steatosis (CAP ≥ 238 dB/m) peaked at 31.2% at year 1 and declined to 28.8% at year 2. Multivariate analysis identified higher BMI (OR 1.55, 95% CI 1.44–1.67; p < 0.001), elevated TG (OR 1.44, 95% CI 1.22–1.70; p < 0.001), and elevated LDL-C (OR 1.90, 95% CI 1.21–2.98; p = 0.005) as independent risk factors. Conclusion: INSTI-based ART was associated with sustained weight gain but did not worsen long-term dyslipidemia compared to an EFV-based regimen in a real-world setting. Hepatic steatosis correlated with metabolic parameters rather than INSTI exposure.
- Open Access
- 14 August 2025
- Published by Wolters Kluwer Health in Infectious Diseases & Immunity
- Vol. 5 (4) , 249-259
HBsAg loss in HIV/HBV coinfected patients: Hepatitis B cure insights and implications
HIV (human immunodeficiency virus)/HBV (hepatitis B virus) coinfection remains a significant public health challenge. HIV infection affects the natural course of chronic HBV infection, with HIV/HBV coinfected patients experiencing higher liver-related morbidity, hospitalization rates, and mortality than those with HBV monoinfection. Surprisingly, an increasing number of studies have shown that hepatitis B surface antigen (HBsAg) clearance rates in HIV/HBV coinfection can reach over 10%, which is significantly higher than in HBV monoinfection. In this review, we summarize the predictive factors for HBsAg clearance observed in HIV/HBV coinfection, including baseline HBsAg levels, baseline HBV DNA levels, baseline CD4+T cell-counts, and immune reconstitution inflammatory syndrome-related hepatic flare. Based on current evidence, we further discuss a potential mechanism for HBsAg clearance: HIV-induced immunodeficiency, particularly the depletion of CD4+ T cells, may unexpectedly disrupt preexisting HBV-specific tolerance. After antiretroviral therapy (ART) in HIV/HBV coinfected individuals, partial immune system reconstitution occurs, and the reconstituted immune system, no longer tolerized by HBV, effectively clears HBV-infected hepatocytes, triggering transient hepatitis and ultimately achieving a functional cure through HBsAg clearance. Additionally, emerging data suggest that the underlying immunological mechanisms of HBsAg clearance in HIV/HBV coinfection may primarily involve: PD-1/PD-L1 pathway inhibition, cytokine induction promoting immune cell recruitment and an inflammatory environment, and natural killer (NK) cell functional remodeling. These collective observations highlight the important role of immune modulation in HBV clearance, providing insights that can facilitate the development of a functional HBV cure. Identifying the mechanisms involved in HBsAg loss in HIV/HBV patients may facilitate the development of drugs that mimic these anti-HBV responses.
- 14 August 2025
- Published by Wolters Kluwer Health in Infectious Diseases & Immunity
- Vol. 5 (4) , 249-259
Open AccessHBsAg loss in HIV/HBV coinfected patients: Hepatitis B cure insights and implications
HIV (human immunodeficiency virus)/HBV (hepatitis B virus) coinfection remains a significant public health challenge. HIV infection affects the natural course of chronic HBV infection, with HIV/HBV coinfected patients experiencing higher liver-related morbidity, hospitalization rates, and mortality than those with HBV monoinfection. Surprisingly, an increasing number of studies have shown that hepatitis B surface antigen (HBsAg) clearance rates in HIV/HBV coinfection can reach over 10%, which is significantly higher than in HBV monoinfection. In this review, we summarize the predictive factors for HBsAg clearance observed in HIV/HBV coinfection, including baseline HBsAg levels, baseline HBV DNA levels, baseline CD4+T cell-counts, and immune reconstitution inflammatory syndrome-related hepatic flare. Based on current evidence, we further discuss a potential mechanism for HBsAg clearance: HIV-induced immunodeficiency, particularly the depletion of CD4+ T cells, may unexpectedly disrupt preexisting HBV-specific tolerance. After antiretroviral therapy (ART) in HIV/HBV coinfected individuals, partial immune system reconstitution occurs, and the reconstituted immune system, no longer tolerized by HBV, effectively clears HBV-infected hepatocytes, triggering transient hepatitis and ultimately achieving a functional cure through HBsAg clearance. Additionally, emerging data suggest that the underlying immunological mechanisms of HBsAg clearance in HIV/HBV coinfection may primarily involve: PD-1/PD-L1 pathway inhibition, cytokine induction promoting immune cell recruitment and an inflammatory environment, and natural killer (NK) cell functional remodeling. These collective observations highlight the important role of immune modulation in HBV clearance, providing insights that can facilitate the development of a functional HBV cure. Identifying the mechanisms involved in HBsAg loss in HIV/HBV patients may facilitate the development of drugs that mimic these anti-HBV responses.
- Open Access
- 13 August 2024
- Published by Oxford University Press (OUP) in Sexual Medicine
- Vol. 12 (4) , qfae060
Sexual difficulties in men who have sex with men living with HIV: their mental health and health-related quality of life
Health-related quality of life (HRQoL) is gaining significance for people living with human immunodeficiency virus (HIV), with sexual difficulties being a crucial yet frequently neglected component of HRQoL, especially in HIV-positive men who have sex with men (MSM). The study sought to assess the levels of sexual difficulties and explore the associations between sexual difficulties, mental health, and HRQoL in HIV-positive MSM. A cohort of 475 HIV-positive MSM was studied from January 2017 to December 2021. Sociodemographic, clinical, and lifestyle data were collected. Participants were divided based on Arizona Sexual Experience Scale (ASEX) scores into 2 groups: those with sexual difficulties and a control group without difficulties. Psychological symptoms were evaluated by the Symptom Checklist-90 (SCL-90), HRQoL was accessed via 36-item Short Form Health Survey, and sexual function was assessed using the ASEX. We also employed path analysis to unveil latent mechanisms, alongside multivariate analysis to identify independent factors, and aimed to elucidate the interplay among sexual function, HRQoL, and mental health in HIV-positive MSM. A total of 391 HIV-positive MSM were enrolled in the control group and 84 in the sexual difficulties group. The control group had significantly higher physical HRQoL (P = .004) and mental HRQoL (P = .045). In addition, SCL-90 scores were higher in the sexual difficulties group (P = .001). Multivariate analyses that indicated regular exercise (odds ratio, 0.553; P = .024) and alcohol consumption (odds ratio, 1.780; P = .033) were independent factors associated with sexual difficulties. The proportion of alcohol consumption in the sexual difficulties group was significantly higher (P = .003). ASEX scores increased gradually with increasing frequency of alcohol consumption (P = .031). Results from structural equation model showed a negative association between HRQoL and ASEX scores (β = −0.13, P < .001) and SCL-90 scores (β = −0.40, P < .001). HIV-positive MSM experiencing sexual difficulties exhibited lower HRQoL and worse mental health, with independent associations identified for regular exercise and alcohol consumption in relation to sexual difficulties. Our research has pioneered in demonstrating that HRQoL mediates the relationship between sexual difficulties and psychological symptoms among HIV-positive MSM undergoing highly active antiretroviral therapy. We found the protective factor associated with sexual difficulties was regular exercise while the risk factor was alcohol consumption. However, the data were collected only from China, and it is still unclear how HRQoL changes after intervention. Routine follow-up for people living with HIV should encompass an investigation into sexual function, emphasizing the need for timely assessment and intervention, particularly in HIV-positive MSM with identified risk factors.
- 13 August 2024
- Published by Oxford University Press (OUP) in Sexual Medicine
- Vol. 12 (4) , qfae060
Open AccessSexual difficulties in men who have sex with men living with HIV: their mental health and health-related quality of life
Health-related quality of life (HRQoL) is gaining significance for people living with human immunodeficiency virus (HIV), with sexual difficulties being a crucial yet frequently neglected component of HRQoL, especially in HIV-positive men who have sex with men (MSM). The study sought to assess the levels of sexual difficulties and explore the associations between sexual difficulties, mental health, and HRQoL in HIV-positive MSM. A cohort of 475 HIV-positive MSM was studied from January 2017 to December 2021. Sociodemographic, clinical, and lifestyle data were collected. Participants were divided based on Arizona Sexual Experience Scale (ASEX) scores into 2 groups: those with sexual difficulties and a control group without difficulties. Psychological symptoms were evaluated by the Symptom Checklist-90 (SCL-90), HRQoL was accessed via 36-item Short Form Health Survey, and sexual function was assessed using the ASEX. We also employed path analysis to unveil latent mechanisms, alongside multivariate analysis to identify independent factors, and aimed to elucidate the interplay among sexual function, HRQoL, and mental health in HIV-positive MSM. A total of 391 HIV-positive MSM were enrolled in the control group and 84 in the sexual difficulties group. The control group had significantly higher physical HRQoL (P = .004) and mental HRQoL (P = .045). In addition, SCL-90 scores were higher in the sexual difficulties group (P = .001). Multivariate analyses that indicated regular exercise (odds ratio, 0.553; P = .024) and alcohol consumption (odds ratio, 1.780; P = .033) were independent factors associated with sexual difficulties. The proportion of alcohol consumption in the sexual difficulties group was significantly higher (P = .003). ASEX scores increased gradually with increasing frequency of alcohol consumption (P = .031). Results from structural equation model showed a negative association between HRQoL and ASEX scores (β = −0.13, P < .001) and SCL-90 scores (β = −0.40, P < .001). HIV-positive MSM experiencing sexual difficulties exhibited lower HRQoL and worse mental health, with independent associations identified for regular exercise and alcohol consumption in relation to sexual difficulties. Our research has pioneered in demonstrating that HRQoL mediates the relationship between sexual difficulties and psychological symptoms among HIV-positive MSM undergoing highly active antiretroviral therapy. We found the protective factor associated with sexual difficulties was regular exercise while the risk factor was alcohol consumption. However, the data were collected only from China, and it is still unclear how HRQoL changes after intervention. Routine follow-up for people living with HIV should encompass an investigation into sexual function, emphasizing the need for timely assessment and intervention, particularly in HIV-positive MSM with identified risk factors.
- Open Access
- 1 May 2024
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 17, 1999-2010
Estimated Pulse Wave Velocity as a Novel Non-Invasive Biomarker for Metabolic Syndrome Among People Living with HIV
Purpose: This study aims to investigate the relationship between estimated pulse wave velocity (ePWV) and metabolic syndrome (MetS) in people living with HIV (PLWH), proposing a novel and convenient predictor for early detection of MetS in PLWH. Patients and Methods: A total of 485 PLWH were enrolled. These participants were categorized into two groups based on the estimated pulse wave velocity (ePWV) level. Demographic and clinical data were collected to investigate the correlation between ePWV and MetS. Results: The cohort of 485 PLWH was categorized into high-ePWV and low-ePWV groups based on ePWV cutoff value of 10 m/s. We observed significant differences in components of MetS including triglycerides (TG, P < 0.05), HDL cholesterol (HDL-C, P < 0.01), systolic blood pressure (SBP, P < 0.001), diastolic blood pressure (DBP, P < 0.05), and fasting plasma glucose (FPG, P < 0.001) between the two groups. Furthermore, we employed receiver operating characteristic (ROC) curves to demonstrate the effectiveness of ePWV as a predictive indicator for MetS in PLWH (AUC = 0.739, P < 0.001). According to the ROC curve, the optimal cut-off value of ePWV was 7.4 m/s, and its sensitivity and specificity in diagnosing MetS in PLWH were 79.03% and 64.07%, respectively. Although the 7.4 m/s cutoff increased the false positive rate compared to the traditional cutoff, it significantly reduced the rate of missed diagnoses, effectively identifying 79.03% of PLWH with MetS. Conclusion: ePWV is a non-invasive and convenient novel biomarker with predictive capabilities for MetS in PLWH.
- 1 May 2024
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 17, 1999-2010
Open AccessEstimated Pulse Wave Velocity as a Novel Non-Invasive Biomarker for Metabolic Syndrome Among People Living with HIV
Purpose: This study aims to investigate the relationship between estimated pulse wave velocity (ePWV) and metabolic syndrome (MetS) in people living with HIV (PLWH), proposing a novel and convenient predictor for early detection of MetS in PLWH. Patients and Methods: A total of 485 PLWH were enrolled. These participants were categorized into two groups based on the estimated pulse wave velocity (ePWV) level. Demographic and clinical data were collected to investigate the correlation between ePWV and MetS. Results: The cohort of 485 PLWH was categorized into high-ePWV and low-ePWV groups based on ePWV cutoff value of 10 m/s. We observed significant differences in components of MetS including triglycerides (TG, P < 0.05), HDL cholesterol (HDL-C, P < 0.01), systolic blood pressure (SBP, P < 0.001), diastolic blood pressure (DBP, P < 0.05), and fasting plasma glucose (FPG, P < 0.001) between the two groups. Furthermore, we employed receiver operating characteristic (ROC) curves to demonstrate the effectiveness of ePWV as a predictive indicator for MetS in PLWH (AUC = 0.739, P < 0.001). According to the ROC curve, the optimal cut-off value of ePWV was 7.4 m/s, and its sensitivity and specificity in diagnosing MetS in PLWH were 79.03% and 64.07%, respectively. Although the 7.4 m/s cutoff increased the false positive rate compared to the traditional cutoff, it significantly reduced the rate of missed diagnoses, effectively identifying 79.03% of PLWH with MetS. Conclusion: ePWV is a non-invasive and convenient novel biomarker with predictive capabilities for MetS in PLWH.
- 8 May 2022
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 44 (5) , 451-458
Association between hypertension and prognosis of patients with COVID-19: A systematic review and meta-analysis
To investigate the association between hypertension and clinical outcomes, including in-hospital mortality, intensive care unit (ICU) admission, and invasive ventilation in patients with coronaviru...
- 8 May 2022
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 44 (5) , 451-458
Association between hypertension and prognosis of patients with COVID-19: A systematic review and meta-analysis
To investigate the association between hypertension and clinical outcomes, including in-hospital mortality, intensive care unit (ICU) admission, and invasive ventilation in patients with coronaviru...
- Open Access
- 6 January 2022
- Published by Frontiers Media SA in Frontiers in Psychology
- Vol. 12, 770415
Risk Factors Associated With Quality of Life in Patients With Hepatitis B Virus Related Cirrhosis
Aim: To evaluate health-related quality of life (HRQoL) of chronic hepatitis B (CHB) and hepatitis B virus (HBV) related cirrhosis patients and analyzed specific differences in all dimensions of HRQoL.Methods: A total of 349 patients met selection criteria were enrolled. The 36-Item Short-Form Health Survey was adopted.Results: Results showed that the physiological HRQoL of the cirrhotic group was significantly lower than that of the non-cirrhotic group (P = 0.003), the psychological HRQoL was also lower (P = 0.006). HRQoL was significantly negatively correlated with liver stiffness (P = 0.001). We further evaluated the risk factors associated with poor HRQoL in HBV-related cirrhosis patients. Results showed that positive HBV DNA viral load (OR = 6.296, P = 0.041) and HCC family history (OR = 36.211, P = 0.001) were independent factors associated with HRQoL in HBV-related cirrhosis. For better risk stratification of patients, multivariable analyses were conducted to explore the independent factors that affected specific physiological and psychological HRQoL. In specific physiological HRQoL, results show that marital status (OR = 9.971, P = 0.034), positive HBV DNA viral load (OR = 6.202, P = 0.042) and antiviral drugs (OR = 0.45, P = 0.031) were independent factors associated with physiological HRQoL in cirrhosis patients. In psychological HRQoL, only HCC family history was independent risk factors associated with psychological HRQoL (OR = 42.684, P = 0.002).Conclusion: We found that the impaired HRQoL dimensions of HBV related cirrhosis patients differ between the various subpopulations. According to our results, risk stratification, medical decision making and personalizing interventions could be made.
- 6 January 2022
- Published by Frontiers Media SA in Frontiers in Psychology
- Vol. 12, 770415
Open AccessRisk Factors Associated With Quality of Life in Patients With Hepatitis B Virus Related Cirrhosis
Aim: To evaluate health-related quality of life (HRQoL) of chronic hepatitis B (CHB) and hepatitis B virus (HBV) related cirrhosis patients and analyzed specific differences in all dimensions of HRQoL.Methods: A total of 349 patients met selection criteria were enrolled. The 36-Item Short-Form Health Survey was adopted.Results: Results showed that the physiological HRQoL of the cirrhotic group was significantly lower than that of the non-cirrhotic group (P = 0.003), the psychological HRQoL was also lower (P = 0.006). HRQoL was significantly negatively correlated with liver stiffness (P = 0.001). We further evaluated the risk factors associated with poor HRQoL in HBV-related cirrhosis patients. Results showed that positive HBV DNA viral load (OR = 6.296, P = 0.041) and HCC family history (OR = 36.211, P = 0.001) were independent factors associated with HRQoL in HBV-related cirrhosis. For better risk stratification of patients, multivariable analyses were conducted to explore the independent factors that affected specific physiological and psychological HRQoL. In specific physiological HRQoL, results show that marital status (OR = 9.971, P = 0.034), positive HBV DNA viral load (OR = 6.202, P = 0.042) and antiviral drugs (OR = 0.45, P = 0.031) were independent factors associated with physiological HRQoL in cirrhosis patients. In psychological HRQoL, only HCC family history was independent risk factors associated with psychological HRQoL (OR = 42.684, P = 0.002).Conclusion: We found that the impaired HRQoL dimensions of HBV related cirrhosis patients differ between the various subpopulations. According to our results, risk stratification, medical decision making and personalizing interventions could be made.
- Open Access
- 1 January 2022
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 15, 407-415
aMAP Score as a Predictor for Long-Term Outcomes in Patients with HBV-Related Acute-on-Chronic Liver Failure
Background and Aim: The long‐term outcomes of patients with hepatitis B virus-related acute-on-chronic liver failure (HBV‐ACLF) remain not well known. This study aimed to investigate whether aMAP score can predict re-hospitalization, hepatocellular carcinoma (HCC) occurrence and long-term mortality in patients with HBV-ACLF. Methods: A total of 82 patients diagnosed with HBV-ACLF and survived over 6 months were enrolled. The median follow-up period was 105 (75.9, 134.1) months. The Cox proportional hazards or logistic regression analysis was used to determine independent risk factors. Cumulative incidence of HCC and survival rate were evaluated using Kaplan–Meier analysis. Results: Multivariate analysis identified that the aMAP risk score was an independent predictor of re-hospitalization (odds ratio [OR] = 1.112, 95% confidence interval [CI]: 1.021– 1.211, p = 0.015), hepatocellular carcinoma occurrence (hazards ratio [HR] = 2.277, 95% CI: 1.014– 5.114, p = 0.046) and mortality (HR = 1.366, 95% CI: 1.040– 1.794, p = 0.025). High-risk aMAP scores were associated with higher risk of HCC occurrence and mortality. Conclusion: A higher aMAP score was an independent risk predictor of re-hospitalization, HCC occurrence and mortality, respectively, in HBV-ACLF patients who survived over 6 months, which can be applicable for early risk stratification and clinical decision.
- 1 January 2022
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 15, 407-415
Open AccessaMAP Score as a Predictor for Long-Term Outcomes in Patients with HBV-Related Acute-on-Chronic Liver Failure
Background and Aim: The long‐term outcomes of patients with hepatitis B virus-related acute-on-chronic liver failure (HBV‐ACLF) remain not well known. This study aimed to investigate whether aMAP score can predict re-hospitalization, hepatocellular carcinoma (HCC) occurrence and long-term mortality in patients with HBV-ACLF. Methods: A total of 82 patients diagnosed with HBV-ACLF and survived over 6 months were enrolled. The median follow-up period was 105 (75.9, 134.1) months. The Cox proportional hazards or logistic regression analysis was used to determine independent risk factors. Cumulative incidence of HCC and survival rate were evaluated using Kaplan–Meier analysis. Results: Multivariate analysis identified that the aMAP risk score was an independent predictor of re-hospitalization (odds ratio [OR] = 1.112, 95% confidence interval [CI]: 1.021– 1.211, p = 0.015), hepatocellular carcinoma occurrence (hazards ratio [HR] = 2.277, 95% CI: 1.014– 5.114, p = 0.046) and mortality (HR = 1.366, 95% CI: 1.040– 1.794, p = 0.025). High-risk aMAP scores were associated with higher risk of HCC occurrence and mortality. Conclusion: A higher aMAP score was an independent risk predictor of re-hospitalization, HCC occurrence and mortality, respectively, in HBV-ACLF patients who survived over 6 months, which can be applicable for early risk stratification and clinical decision.
- Open Access
- 1 September 2021
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 14, 3817-3825
Association Between Nutritional Risk Screening Score and Prognosis of Patients with Sepsis
Background: Malnutrition is one of the most critical factors affecting patients’ risk of infection and length of stay, and it may affect the prognosis of patients with sepsis. There have been no studies that have applied nutritional risk screening tools to stratify patients with sepsis according to prognosis. Methods: We retrospectively analyzed the clinical data of 425 adult sepsis inpatients who were grouped based on nutritional risk screening (NRS) score, including a nutrition score, disease severity score, and age score. Prognostic factors were analyzed using univariate and multivariate regression analyses. Results: Of the enrolled patients, 174 had an NRS score of ≥ 3; these patients were older and had a longer hospitalization time but lower body mass index (BMI), albumin (ALB) than others. Univariate Cox regression analysis showed that age, ALB, C-reactive protein (CRP), and NRS score were significantly (P< 0.05) associated with in-hospital mortality. Multivariate analysis showed that age (hazard ratio [HR]=1.020, 95% confidence interval [CI]: 1.005– 1.036; P=0.008) and ALB (HR=0.924, 95% CI: 0.885– 0.966; P< 0.001) were independent risk factors for sepsis-related mortality. The Kaplan–Meier analysis revealed that the cumulative in-hospital mortality of sepsis patients with an NRS score of ≥ 3 was significantly higher than that of patients with an NRS score of < 3 (P=0.022). Conclusion: NRS scores can effectively risk stratify sepsis patients. Patients with high NRS scores should be monitored more closely to halt further disease progression.
- 1 September 2021
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 14, 3817-3825
Open AccessAssociation Between Nutritional Risk Screening Score and Prognosis of Patients with Sepsis
Background: Malnutrition is one of the most critical factors affecting patients’ risk of infection and length of stay, and it may affect the prognosis of patients with sepsis. There have been no studies that have applied nutritional risk screening tools to stratify patients with sepsis according to prognosis. Methods: We retrospectively analyzed the clinical data of 425 adult sepsis inpatients who were grouped based on nutritional risk screening (NRS) score, including a nutrition score, disease severity score, and age score. Prognostic factors were analyzed using univariate and multivariate regression analyses. Results: Of the enrolled patients, 174 had an NRS score of ≥ 3; these patients were older and had a longer hospitalization time but lower body mass index (BMI), albumin (ALB) than others. Univariate Cox regression analysis showed that age, ALB, C-reactive protein (CRP), and NRS score were significantly (P< 0.05) associated with in-hospital mortality. Multivariate analysis showed that age (hazard ratio [HR]=1.020, 95% confidence interval [CI]: 1.005– 1.036; P=0.008) and ALB (HR=0.924, 95% CI: 0.885– 0.966; P< 0.001) were independent risk factors for sepsis-related mortality. The Kaplan–Meier analysis revealed that the cumulative in-hospital mortality of sepsis patients with an NRS score of ≥ 3 was significantly higher than that of patients with an NRS score of < 3 (P=0.022). Conclusion: NRS scores can effectively risk stratify sepsis patients. Patients with high NRS scores should be monitored more closely to halt further disease progression.